Literature DB >> 8151852

Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus.

S K Garg1, H P Chase, G Marshall, S L Hoops, D L Holmes, W E Jackson.   

Abstract

OBJECTIVE: To evaluate the effects of oral contraceptives (OCs) as a possible risk factor for early diabetic renal and/or retinal complications.
DESIGN: A retrospective case-control study.
SETTING: A university hospital diabetes clinic. PARTICIPANTS: Forty-three diabetic women who used OCs for 1 year or longer (mean, 3.4 years; range, 1.0 to 7.0 years) were compared with a computer-matched control group of 43 diabetic women who never used OCs. MAIN OUTCOME MEASURES: Hemoglobin A1c levels, albumin excretion rates, and mean retinopathy scores.
RESULTS: The mean +/- SEM age and duration of diabetes were 22.7 +/- 0.5 years (range, 17.1 to 30.5 years) and 13.8 +/- 0.8 years, respectively, for the study group. The mean longitudinal hemoglobin A1c values were similar for study subjects and control subjects. The final mean albumin excretion rates, reflecting diabetic renal damage, and the mean eye grades were not significantly different between the groups.
CONCLUSIONS: The use of OCs among young women with insulin-dependent diabetes mellitus does not pose an additional risk for the development of early diabetic retinopathy and/or nephropathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151852

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  A systematic review of drug induced ocular reactions in diabetes.

Authors:  J P Hampson; J N Harvey
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Oral contraception and eye disease: findings in two large cohort studies.

Authors:  M P Vessey; P Hannaford; J Mant; R Painter; P Frith; D Chappel
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 3.  Putting risk into perspective: the US medical eligibility criteria for contraceptive use.

Authors:  Kathryn M Curtis; Naomi K Tepper; Polly A Marchbanks
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

Review 4.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

5.  How does gestational diabetes affect postpartum contraception in nondiabetic primiparous women?

Authors:  Hind A Beydoun; May A Beydoun; Hala Tamim
Journal:  Contraception       Date:  2008-12-11       Impact factor: 3.375

Review 6.  Estrogens and the diabetic kidney.

Authors:  Christine Maric; Shannon Sullivan
Journal:  Gend Med       Date:  2008

7.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

8.  Diabetes and pregnancy: an endocrine society clinical practice guideline.

Authors:  Ian Blumer; Eran Hadar; David R Hadden; Lois Jovanovič; Jorge H Mestman; M Hassan Murad; Yariv Yogev
Journal:  J Clin Endocrinol Metab       Date:  2013-11       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.